TauRx’s Hydromethylthionine Mesylate (HMTM) Demonstrates Significant Reduction in Neurodegeneration in Alzheimer’s Disease (AD)
Author of the article: Published Jul 16, 2023 • 3 minute read Results from a prespecified analysis of the Phase ...
Read moreDetails
